In Sept. 2010, the U.S. Food and Drug Administration announced that it will significantly restrict the use of the diabetes drug Avandia (rosiglitazone) to patients with Type 2 diabetes who cannot control their diabetes on other medications. These new restrictions are in response to data that suggest an elevated risk of cardiovascular events, such as heart attack and stroke, in patients treated with Avandia.
Avandia 2007 Black Box Warning: In 2007, the FDA issued a Black Box Warning that Avandia® could potentially increase the risk of damage to a patients' heart.
According to the FDA alert, "Safety data from controlled clinical trials have shown that there is a potentially significant increase in the risk of heart attack and heart related deaths in patients taking Avandia®." The Black Box warning is the highest level of alert and suggests a significant risk of serious or life threatening side effects.
The American Heart Association reports that people with moderate or severe congestive heart failure should not use these glucose lowering drugs. The study concluded that diabetics who have mild heart disease or any problems with their kidneys could be at a greater risk of developing congestive heart failure if they take Avandia®.
At Peterson & Associate, P.C. we are determined to get justice for the victims of Avandia® and to seek compensation for their suffering.
If you or someone you know has suffered from Avandia®, please contact our defective drugs lawyer immediately by calling 1-800-305-7552 or to contact us online, simply fill out and send the "Free Case Evaluation" form on this page.
We proudly offer Avandia® injury victims 100% FREE consultations and we only get paid if we obtain a recovery on your behalf.